QUOTE FOR THE WEEKEND:

“The American Heart Association states November 20, 2023 the following:

The turkey is roasting in the oven. The pies are cooling on the counter. And you may be telling yourself, “Thanksgiving Day is no time to be overly rigid about what I’m eating.”

Health experts say – you might have a point.

“I don’t want people overthinking their relationship with food during Thanksgiving, when the holiday should be about friends, families, being thankful and counting our blessings,” said Dr. Colleen Spees, an associate professor of medical dietetics at Ohio State University College of Medicine in Columbus.

Holidays tend to bring out all-or-nothing attitudes about eating, said Krystal Dunham, a registered dietitian nutritionist in Tulsa, Oklahoma. People are either “YOLO! It’s the holidays! I’m going to let all the rules go!” or “It’s the holidays, and I’m not touching anything unless it’s celery.”

“And I think there’s a way to exist in the middle,” Dunham said.

That middle ground allows for enjoyment, peace of mind and health, she and Spees said. And while some people, including those with diet-related medical conditions such as diabetes, might require more thoughtful planning, everyone can make simple, healthy last-minute choices that enhance the day.”

American Heart Association (Ideas for keeping Thanksgiving healthy – and happy | American Heart Association)

Due to it being around the corner, learn what happens to the body after a traditional Thanksgiving meal and more!

We’ve made countless jokes about our “Thanksgiving pants“ and planned belt unbuckling as we prepare to indulge in a big meal on Thursday. And, in case you missed it, we’ve also done our best to calculate the number of calories we might consume if we don’t rein it in a little bit. But what actually happens to your system when you overeat during the holidays?

We asked Dr. Jay Kuemmerle, a gastroenterologist and professor of medicine at Virginia Commonwealth University and Dr. Daniel Hurley, an endocrinologist and consultant in the Division of Endocrinology, Diabetes, Metabolism and Nutrition at the Mayo Clinic, Rochester to walk us through how our bodies really handle the feast before us.

“The main difference that relates to Thanksgiving is the volume and constituents of the meal,” says Kuemmerle. “In large part the high fat can lead to feeling very full and slower digestion. This can cause the stomach to expand to a greater degree, which can be uncomfortable.”

Uncomfortable how? Well, as the stomach gets more distended from overeating, the growing pressure is relieved by releasing gas — that means some people will experience acid reflux and the urge to belch. Kuemmerle suggests thinking of the stomach as a balloon: It has some elasticity, but eventually reaches a breaking point and must relieve pressure.

Our bodies have a natural stopping point, but the brain is capable of overriding the stomach’s wishes to stop eating. That’s particularly true during a holiday meal, where variety and abundance are prized.

“There’s some suggestion that a wide variety of food, like at the Thanksgiving meal, tends to increase food intake,” says Hurley. This is often referred to as the “smorgasbord effect,” according to the Columbia University Press.

Thanksgiving differs from other meals mostly in ritual: The holiday prizes tradition over digestive mindfulness, hence the problems with variety and satiety. But in all other ways, the meal looks about the same to your digestive tract. (Which may be a comment on our abundant year-round food supply and not this holiday of abundance).

Below, how digestion works — on Thanksgiving and on all other days:

It turns out the expression “feast your eyes” is pretty dead on. As soon as you sit down at the table, the sight and smell of the food sends a signal to the brain and then down to the stomach to prime your digestive system for the meal, according to Kuemmerle.

That means, at the very first bite, your stomach is primed and ready to go. “When the first bite of food hits the stomach, it’s already revved up: acid and digestive enzymes have been released,” says Kuemmerle. “The stomach starts to expand to accomodate the meal.”

Your mouth plays a role too. “As food is chewed, digestive juice from the salivary glands starts the digestion,” explains Hurley. “The teeth involved in mastication break down the food into protein, carb, fat and then in the stomach, breakdown continues.”

As you eat, your stomach stretches and secretes acid and digestive enzymes to help digest the food. Once you get to a point where your stomach feels full, stretch receptors — a collection of sensory nerves in the stomach — send messages to the brain to tell it that it’s time to stop eating.

Again, this is where your brain can really misguide your body. “When we eat, ghrelin — the hormone that stimulates back to brain to say I’m full or I’m hungry — increases and activates the hunger or satiety centers in the hypothalamus of the brain,” explains Hurley. “But your central nervous system can override the hypothalamus — it’s the same reason we can stay awake, even if our brain is telling us we’re tired.”

Once your body determines fullness, the stomach grinds the food down into two to three millimeter pieces — small enough to fit into the small intestine. As the stomach does this, it begins to contract and reestablish its tone, while pushing the ground up matter and digestive liquid through the pylorus and into the duodenum, which is the upper part of the small intestine.

This process can be slowed, depending on what you ate. “A high fat meal with gravy and butter delays emptying of the stomach because fat is harder to digest,” says Kuemmerle. In other words? Your stomach’s ability to efficiently process its contents may rely on how much butter your Aunt Mable put in those mashed potatoes. This can delay stomach emptying, which is an important step of digestion because the food’s presence in the small intestine signals the release of important enzymes from the pancreas and galbladder. These pancreatic enzymes and bile help to digest carbs and proteins and emulsify fats, breaking the food down into amino acids and simple sugars to be absorbed into the blood stream.

Of note, Hurley explains, our metabolism can actually increase if we eat too much to help with digestion, which requires energy. But don’t get too excited, he says, “it’s not enough to overcome the calories we don’t need — it’s just enough to help us.”

The release of sugar in the blood stream triggers insulin, the hormone responsible for regulating blood sugar. Insulin and another hormone glucagon will store some sugar in the liver as glycogen (some fat is also stored in the liver). Every cell of your body requires glucose and muscles also requires a store of glycogen. What the body doesn’t use for these functions will be sent to fat tissue to be stored as fat — either subcutaneous fat or abdominal visceral fat.

As the digested material hits the end of the small intestine, specific vitamins get absorbed, bile gets reabsorbed and hormonal signals are sent to the brain.

Next, the body performs a really fascinating self-cleaning maneuver: As the matter continues into the colon (where water is reabsorbed and some additional nutrients are absorbed, according to Kuemmerle), the interdigestive period begins. All of the “indigestible material” — the detritus that didn’t make it through the first time — gets pushed through. The pylorus opens widely and the bigger stuff gets swept into the colon. A gallbladder contraction allows the pancreatic duct to get cleaned out. It is, Kuemmerle explains, a form of housekeeping to prep the body for the next meal.

“While the [conscious] brain is involved in chewing and swallowing and ‘starting’ the machinery,” says Kuemmerle. “The vast number of functions occur in the GI tract without us being able to regulate or be aware of it.”

And here you thought you were just sitting on the couch.

QUOTE FOR FRIDAY:

“Radon is a gas that you cannot smell, taste, or see. It comes naturally from rocks and soil and can dissolve in groundwater. Radon is the second leading cause of lung cancer in the United States after cigarette smoke.

People can be exposed to radon mainly from breathing radon in air that comes through cracks and gaps in the foundation of buildings and homes. Get your home tested for radon and take steps to reduce the radon level if it is high.”

The EPA and the Surgeon General’s office estimate radon is responsible for more than 21,000 lung cancer deaths each year in the United States.

When you breathe in radon, radioactive particles from the decay of radon gas can get trapped in your lungs. It takes many years for lung cancer to develop. Most people don’t have symptoms until lung cancer is advanced and at that point it is harder to treat. For these reasons, it is important to take steps to reduce radon exposure throughout your life to help prevent lung cancer.”

Center for Disease Control and Prevention – CDC (Radon and Your Health | Radon | CDC)

Part IV Lung Cancer Awareness Month – diagnosing and treatment options for Lung Cancer!

For many people, the first sign that they may have lung cancer is the appearance of a suspicious spot on a chest x-ray or a CT scan. But an image alone is not enough to tell you whether you have cancer and, if so, what type of cancer it is.

Most people who come to us for a lung cancer diagnosis first meet with a surgeon. He or she will work with pathologists, radiologists, and other lung cancer specialists to determine the specific type of lung cancer you have and how advanced it is. These findings help your disease management team develop the most successful treatment plan for you.

The first step is for your doctor to get a tissue sample using one of several biopsy methods. Then a pathologist — a type of doctor who specializes in diagnosing disease —who focuses on lung cancer studies the tissue under a microscope to determine whether you have lung cancer and, if so, what type. He or she will be able to tell this by looking closely at the cancer cells’ shape and other features.

Knowing which type of lung cancer you have will help your doctors to stage the tumor accurately and to begin identifying the best treatment approach. Understanding what type of cancer you have is also important because each type responds differently to certain chemotherapy drugs.

Testing healthy people for lung cancer

Several organizations recommend people with an increased risk of lung cancer consider annual computerized tomography (CT) scans to look for lung cancer. If you’re 55 or older and smoke or used to smoke, talk with your doctor about the benefits and risks of lung cancer screening.

 Some studies show lung cancer screening saves lives by finding cancer earlier, when it may be treated more successfully. But other studies find that lung cancer screening often reveals more benign conditions that may require invasive testing and expose people to unnecessary risks and worry.

Tests to diagnose lung cancer

If there’s reason to think that you may have lung cancer, your doctor can order a number of tests to look for cancerous cells and to rule out other conditions. In order to diagnose lung cancer, your doctor may recommend:

  • Imaging tests. An X-ray image of your lungs may reveal an abnormal mass or nodule. A CT scan can reveal small lesions in your lungs that might not be detected on an X-ray.
  • Sputum cytology. If you have a cough and are producing sputum, looking at the sputum under the microscope can sometimes reveal the presence of lung cancer cells.
  • Tissue sample (biopsy). A sample of abnormal cells may be removed in a procedure called a biopsy.Your doctor can perform a biopsy in a number of ways, including bronchoscopy, in which your doctor examines abnormal areas of your lungs using a lighted tube that’s passed down your throat and into your lungs; mediastinoscopy, in which an incision is made at the base of your neck and surgical tools are inserted behind your breastbone to take tissue samples from lymph nodes; and needle biopsy, in which your doctor uses X-ray or CT images to guide a needle through your chest wall and into the lung tissue to collect suspicious cells.A biopsy sample may also be taken from lymph nodes or other areas where cancer has spread, such as your liver.

Treatment Options for Lung Cancer Patients

Depending on the type of lung cancer you have and what stage it has progressed to, the treatment options will vary. From aggressive chemotherapy and radiation regimens to surgery and immunotherapy, two patients’ lung cancer journeys can look very different from each other.  Treatment options for lung cancer may involve cutting-edge targeted therapies and immunotherapies. Patients may also be eligible to enroll in clinical trials, where they’ll have early access to the latest innovations. comprehensive palliative care and integrative care.

QUOTE FOR THURSDAY:

“Lung cancer is the most common cause of cancer death in the United States for both men and women. About 63,040 men and 61,950 women are estimated to die from lung cancer in 2026.

According to estimates by the National Cancer Institute, 229,410 patients are expected to receive a diagnosis of lung or bronchus cancer in the United States in 2026. The estimated five-year relative
survival rate is 29.5%.

Smoking is the most common cause of lung cancer in the United States.”

American Association For Cancer Research – AACR (https://www.aacr.org/patients-caregivers/awareness-months/lung-cancer-awareness-month/)

Part III Lung Cancer Awareness Month -Staging of Non-Small Cell Lung Cancer, Small Cell Lung Cancer and How Staging Works!

What is staging and why is it important?

Understanding if and where lung cancer has spread (the stage) is important to determining what options are available for treatment. Imaging tests, biopsies and laboratory tests help to determine staging.

Non-Small Cell Lung Cancer

Non-small cell lung cancer is one of several cancers staged using the TNM system. The cancer is staged according to the size of the tumor (T), the extent to which the cancer has spread to the lymph nodes (N), and the extent to which the cancer has spread beyond the lymph nodes, or metastasis (M).

How Does The TNM Staging System Work?

The TNM staging system:

  • Was created by merging the staging systems of the American Joint Committee on Cancer (AJCC) http://www.cancerstaging.org/ and the International Union Against Cancer (UICC) http://www.uicc.org/ in 1987
  • Is one of the most commonly used cancer staging systems
  • Standardizes cancer staging internationally

T is for Tumor

How big is the tumor? Where is it located? Has it spread to nearby tissue?

TX The primary tumor cannot be assessed, or the presence of a tumor was only proven by the finding of cancer cells in sputum or bronchial washings but not seen in imaging tests or bronchoscopy.
T0 No evidence of a primary tumor.
Tis “In situ” – cancer is only in the area where the tumor started and has not spread to nearby tissues.
T1 The tumor is less than 3 cm (just slightly over 1 inch), has not spread to the membranes that surround the lungs (visceral pleura), and does not affect the air tunes (bronchi) that brand out on either side from the windpipe (trachea).
T1a The tumor is less than 2 cm.
T1b The tumor is larger than 2 cm but less than 3 cm.
T2 The tumor is larger than 3 cm but less than 7 cm or involves the main air tubes (bronchus) that brand out from the windpipe (trachea) or the membranes that surround the lungs (visceral pleura). The tumor may partially block the airways but has not caused the entire lung to collapse (atelectasis) or to develop pneumonia).
T2a The tumor is larger than 3 cm but less than or equal to 5 cm.
T2b The tumor is larger than 5 cm but less than or equal to 7 cm.
T3 The tumor is more than 7 cm or touches an area near the lung (such as the chest wall or diaphragm, or sac surrounding the heart (pericardium) or has grown into the main air tubes (bronchus) that brand out from the windpipe (trachea) but not the area where the windpipe divides or has caused one lunch to collapse (atelectasis) or pneumonia in an entire lung or there is a separate tumor(s) in the same lobe.
T4 The tumor is of any size and has spread to the area between the lungs (mediastinum), heart, trachea, esophagus, backbone or the place where the windpipe (trachea) branches or there is a separate tumor(s) in a different lobe of the same lung.

N is for Lymph Node

Has the cancer spread to the lymph nodes in and around the lungs? For more information on the lymph system and lymph nodes, see Lymph System

NX Regional lymph nodes cannot be assessed.
N0 No cancer found in lymph nodes.
N1 Cancer has spread to lymph nodes within the lung or to the area where the air pipes (bronchus) that branch out from the windpipe enter the lung, but only on the same side of the lung as the tumor (ipsilateral).
N2 Cancer has spread to lymph nodes near where the windpipe (trachea) branches into the left and right air tubes (bronchi) or near the area in the center of the lung (mediastinum) but only on the same side of the lung as the tumor.
N3 Cancer has spread to lymph nodes found on the opposite side of the lung as the tumor (contralateral) or lymph nodes in the neck.

M is for Metastasis

Has the cancer spread to other parts of the body?

MX Cancer spread cannot be assessed
M0 Cancer has not spread.
M1 Cancer has spread.
M1a Cancer has spread: separate tumor(s) in a lobe in the opposite lung from the primary tumor (contralateral), or malignant nodules in the membrane that surround the lung (pleura) or malignant excess fluid (effusion) in the pleura or membrane that surround the hear (pericardium).
M1b Cancer has spread to distant part of the body such as brain, kidney, bone.

Stages

After the Tumor (T), Lymph Nodes (N) and Metastasis (M) have been determined, the cancer is then staged accordingly:

Overall Stage T N M
Stage 0 Tis (in situ) N0 M0
Stage IA T1a, b N0 M0
Stage IB T2a N0 M0
Stage IIA T1a, b
T2a
T2b
N1
N1
N0
M0
M0
M0
Stage IIB T2b
T3
N1
N0
M0
M0
Stage IIIA T1, T2
T3
T4
N2, N1
N2, N0
N1
M0
M0
M0
Stage IIIB T4
Any T
N2
N3
M0
M0
Stage IV Any T Any N M1a, b

Small Cell Lung Cancer

Small cell lung cancer is most often staged as either limited-stage or extensive-stage.

Limited-Stage

Indicates that the cancer has not spread beyond one lung and the lymph nodes near that lung.

Extensive-Stage

The cancer is in both lungs or has spread to other areas of the body.

Source:

International Association for the Study of Lung Cancer. Goldstraw P, ed. Staging Handbook in Thoracic Oncology. Orange Park: Editorial Rx Press; 2009.

QUOTE FOR WEDNESDAY:

“Key Facts:

  • Biomarker testing looks for mutations, insertions, deletions, rearrangements, fusions and other genetic changes in DNA.
  • Biomarker testing can also help look for other key markers like levels of certain proteins or the amount of tumor DNA in the blood.
  • Knowing this information can help your healthcare team identify treatments that may be most effective for your specific type of lung cancer, including targeted therapies and immunotherapy.
  • You can think of your DNA like words in a book. When something goes wrong, the words can have typos which leads to the words in the book meaning something different. In the case of lung cancer, these changes to the “words” can lead to uncontrolled cell growth and cancer. Some lung cancer treatments, called targeted therapies, can “target” these changes directly. These lung cancer treatments often cause fewer side effects because they focus on targeting what is exactly wrong with the cancer cell, instead of killing normal, healthy cells too.”

American Lung Association (Lung Cancer Biomarker Testing: Biomarkers, Results & Treatment | American Lung Association)

Part II Lung Cancer Awareness Month – Learn the 2 most common types of Lung CA & symptoms!

 

When you breathe in, air enters through your mouth and nose and goes into your lungs through the trachea (windpipe). The trachea divides into tubes called the bronchi (singular, bronchus), which enter the lungs and divide into smaller branches called the bronchioles. At the end of the bronchioles are tiny air sacs known as alveoli.

Many tiny blood vessels run through the alveoli. They absorb oxygen from the inhaled air into your bloodstream and pass carbon dioxide (a waste product from the body) into the alveoli. This is expelled from the body when you exhale. Taking in oxygen and getting rid of carbon dioxide are your lungs’ main functions.

A thin lining called the pleura surrounds the lungs. The pleura protects your lungs and helps them slide back and forth as they expand and contract during breathing. The space inside the chest that contains the lungs is called the pleural space (or pleural cavity).

Below the lungs, a thin, dome-shaped muscle called the diaphragm separates the chest from the abdomen. When you breathe, the diaphragm moves up and down, forcing air in and out of the lungs.

LUNG CANCER

There are 3 types of lungs cancer.  The two most common types of lung cancer that exist are 1 non-small cell lung cancer (NSCLC), which is the most common, and 2 small cell lung cancer (SCLC), an aggressive cancer that occurs in just over 10 percent of all lung cancer cases.

The third group is 3 lung carcinoid tumors (also known as lung carcinoids) are a type of lung cancer, which is a cancer that starts in the lungs. Cancer starts when cells begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas of the body.

Lung carcinoid tumors are uncommon and tend to grow slower than other types of lung cancers. They are made up of special kinds of cells called neuroendocrine cells.

Lung Cancer Symptoms

Both major types of lung cancer have similar symptoms. These symptoms often include a cough that doesn’t go away and shortness of breath.

Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest X-ray done for another condition. Signs and symptoms may be caused by lung cancer or by other conditions. Check with your doctor if you have any of the following:

  • Chest discomfort or pain
  • A cough that doesn’t go away or gets worse over time
  • Trouble breathing
  • Wheezing
  • Blood in sputum (mucus coughed up from the lungs)
  • Hoarseness
  • Loss of appetite
  • Weight loss for no known reason
  • Tiredness/lethargy
  • Trouble swallowing
  • Swelling in the face and/or veins in the neck

For both conditions, early detection through a low-dose computed topography (CT) scan is especially critical. Identifying lung cancer in its earliest stages even before you have symptoms can reduce the risk of death by 20 percent, according to recent studies.

Non-small cell lung Cancer (NSCLC)

Non-small cell lung cancer (NSCLC) is the most common type of cancer in lung tissues. Your risk of developing this disease increases if you are a longtime or former smoker, have been exposed to passive smoke, or have had environmental or occupational exposure to radon, asbestos, uranium, and other substances. The primary types of NSCLC are named for the type of cells found in the cancer:

  • Squamous-cell carcinoma (also called epidermoid carcinoma)
  • Adenocarcinoma
  • Large-cell carcinoma
  • Adenosquamous carcinoma
  • Undifferentiatiated carcinoma

Small Cell Lung Cancer (SCLC)

In small cell lung cancer (SCLC), small cancerous cells arise in the airway, usually in a central location. This is an aggressive cancer that spreads quickly throughout the body through the blood and lymphatic (node) systems. Typically occurring in people who smoke or who used to smoke, SCLC accounts for just over 10 percent of all lung cancers.

QUOTE FOR TUESDAY:

“Lung cancer happens when cells in the lung change (or mutate). Most often, this is because of exposure to dangerous chemicals that we breathe. But lung cancer can also happen in people with no known exposure to toxic substances. Unlike normal cells, cancer cells grow uncontrollably and cluster together to form a tumor, destroying healthy lung tissue around them. Symptoms usually do not appear until cancer cells spread to other parts of the body and prevent other organs from functioning properly. At this point, it is harder to treat lung cancer.”

American Lung Association (Lung Cancer Basics | American Lung Association)

Part I Lung Cancer Awareness Month – Learn facts about risk factors & newer treatments!

You may be surprised to learn that the most deadly cancer among both men and women in the United States isn’t breast cancer: It’s lung cancer.

Although the rate of new lung cancer cases has dropped in recent years along with the smoking rate, lung cancer still accounts for more deaths than any other cancer in both men and women, according to the American Cancer Society.

So even though you’ll probably never see professional athletes sporting pearl-colored gloves and shoes (pearl is the color of the lung cancer ribbon) to raise awareness, it’s important to learn about the disease: who is at risk — not just people who smoke tobacco — how it’s treated and why early detection is the best defense.

Here, Mary Jo Fidler, MD, a medical oncologist at Rush University Medical Center, discusses five things everyone should know about lung cancer.

1. It’s often caused by a combination of factors.

“It’s natural to associate lung cancer with cigarette smoking,” Fidler says. “Although it’s true that smoking is responsible for 80 percent of all lung cancer cases, lung cancer among people who have never smoked is the sixth leading cause of cancer death worldwide.”

These are some of the leading causes of lung cancer among nonsmokers:

  • Exposure to radon gas released from soil and building materials
  • Exposure to asbestos, diesel exhaust and/or industrial chemicals
  • Exposure to secondhand smoke (the U.S. Department of Health and Human Services says secondhand smoke increases a nonsmoker’s lung cancer risk by as much as 20 to 30 percent)
  • Air pollution

And while any of these factors can cause lung cancer on its own, the disease is often the result of interacting factors.

For instance, according to the National Institutes of Health, there is a greater risk for lung cancer when smokers are also exposed to radon gas. And research studies have shown that the combination of smoking and asbestos exposure greatly increases a person’s risk of developing lung cancer vs. both nonsmoking asbestos workers and smokers who are not exposed to asbestos.

Occupational exposures — including asbestos, uranium and coke (a type of fuel used in smelters, blast furnaces and foundries) — can also increase a person’s risk of dying from their lung cancer, according to another study.

2. Genes may play a role in lung cancer risk.

Scientists have discovered that another culprit may be responsible for some nonsmokers getting lung cancer: genetics.

A study published in the journal Nature Genetics identified three genetic variations — two on chromosome 6 and one on chromosome 10 — that are associated with increased lung cancer risk in Asian women who have never smoked.

Findings have shown that the risk of lung cancer among people who never smoked, especially Asian women, may be associated with specific genetic characteristics that distinguish it from lung cancer in smokers.

Another study, published in Cancer, found that a variant in the NFKB1 gene was associated with a 21 to 44 percent reduced risk of lung cancer. Because a protein produced in part of the NFKB1 gene is known to play a significant role in inflammation and immunity by regulating gene expression, cell death and cell production, the study suggests that inflammation and immune response may be associated with lung cancer risk.

Further research is needed, however, to determine whether there’s a cause and effect relationship between this variant in the NFKB1 gene and lung cancer. Future studies may also shed more light on the exact role inflammation plays in lung cancer risk.

3. If you’re at high risk, CT scans are an effective screening tool.

As with other cancers, the key to surviving lung cancer is catching it in the earliest stages, when it’s most treatable.

The five-year survival rate for people whose cancers are diagnosed when they’re still localized — meaning they haven’t yet spread to the lymph node drainage system or other areas of the body — can be as high as 80 to 90 percent; the survival rate plummets to 2 percent if the diagnosis happens after the cancer has spread to other body parts.

Unfortunately, because symptoms (including persistent cough or coughing up blood, unexplained weight loss, persistent chest pain and shortness of breath) don’t usually appear until the later stages, lung cancer is tough to diagnose early.

Low-dose spiral computed tomography (CT) has proven to reduce lung cancer deaths in patients at high risk for lung cancer. In fact, the National Lung Screening Trial found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose spiral CT (versus those screened by chest X-ray).

However, because the scans can also yield false positive results — by mistaking scar tissue or benign lumps for cancer — they’re recommended only for people at high-risk, for whom the benefits of early detection outweigh the risks of potential false positives and repeated exposure from the scans.

Lung cancer screening is recommended for people who meet these criteria:

  • Are between the ages of 55 and 77 (for Medicare coverage) and 55 and 80 (for commercial insurance coverage)
  • Have at least a 30 pack-year smoking history (an average of one pack a day for 30 or more years)
  • Are in good health and have no signs of lung cancer (weight loss or coughing up blood)
  • Have not had a chest CT in the past year.

“Talk to your doctor if you’re in this high-risk group,” says Fidler. “The best evidence we have available tells us that while CT scanning isn’t right for everyone, for those at high risk it does prevent lung cancer deaths by enabling earlier diagnoses.”

We have had a historically huge amount of FDA approvals in a relatively short amount of time for lung cancer therapies, which is good reason for optimism.

4. Some tumors can be removed minimally invasively.

Tumors that are caught in the early stages can often be surgically removed, giving patients a good chance of being cancer-free.

The standard procedure to remove the lobe of the lung in which the tumor is located, known as a lobectomy, typically requires a six-inch incision in the chest through which the ribsare spread apart.

But at a handful of medical centers, including Rush, roughly 80 percent of lobectomies can be done using a minimally invasive approach.

Video-assisted thoracoscopic surgery (VATS) lobectomies are performed through small incisions (and without spreading the rib cage) using a tiny video camera and specialized surgical instruments. There are many benefits to a VATS lobectomy vs. open surgery — including less pain and fewer complications after surgery, less time in the hospital and a speedier recovery — and the results are comparable, making it a good option for many tumors.

5. Newer treatments pack a targeted punch.

Research has yielded a wealth of information about how lung cancer cells change and grow, enabling scientists to develop drugs to specifically address those changes.

These “targeted” drug therapies, used alone or in combination with chemotherapy, are typically less toxic and have fewer side effects than chemotherapy because they zero in on specific genes or proteins more often found in cancer cells then in healthy tissue.

These are some of the targeted therapies currently available for lung cancer

  • Monoclonal antibodies (bevacizumab, ramucirumab)
  • EGFR inhibitors (erlotinib, afatinib, gefitinib)
    • Osimertinib, an EGFR inhibitor that also targets cells with the T790M mutation
    • Necitumumab, an EGRF inhibitor for squamous cell non-small cell lung cancer
  • Drugs that target the ALK gene (crizotinib, ceritinib, alectinib)